Apr 20 2014 @ 18:50
Joining Euronext’s regulated market in Paris (compartment C). EnterNext, the Euronext subsidiary designed to promote and grow its market for SMEs, has admitted TxCell, a French biotechnology company specialising in immunotherapies for the treatment of chronic inflammatory and auto-immune diseases, to its index. TxCell joined Euronext’s regulated market in Paris (compartment C). Founded in...
Apr 13 2014 @ 05:56
At the unit price of €5.35 EnterNext, the Euronext subsidiary designed to promote and grow its market for SMEs, today congratulated Quantum Genomics, a biopharmaceutical research company developing new therapies for cardiovascular disease, on its transfer from the Free Market to Alternext in Paris following a €3.4 million private placement. Quantum Genomics is a biopharmaceutical […]
Apr 10 2014 @ 15:45
EnterNext, the Euronext subsidiary designed to promote and grow its market for SMEs, today announced the listing of SuperSonic Imagine, a company specialized in ultrasound medical imaging, on Euronext’s compartment B in Paris. Founded in 2005 and based in Aix-en-Provence in southern France, SuperSonic Imagine is revolutionising ultrasound technology, a field that had seen no […]
Apr 09 2014 @ 15:27
Order book was “three times oversubscribed” Euronext, a wholly owned subsidiary of IntercontinentalExchange Group (
NYSE:ICE), today announced that NIBC Bank listed its successfully launched EUR 500 million conditional pass through covered bond on Euronext Amsterdam (ISIN XS1054163347). The issue followed the inaugural and innovative EUR 500 million transaction of October 2013, that...
Apr 09 2014 @ 15:14
Alternext is a multilateral trading facility operated in Belgium, France, Portugal and the Netherlands Euronext, a wholly owned subsidiary of IntercontinentalExchange Group (
NYSE:ICE), today announced that, following a strategic review, it will “wind down Alternext Amsterdam by the end of the year, or as soon as possible thereafter”. In a statment Euronext said it “will...
Apr 08 2014 @ 14:04
The interest rate stand at respectively 2.864% and 3.375%. Euronext Group N.V., a wholly owned subsidiary of IntercontinentalExchange Group (
NYSE:ICE), announces the successful bond listing by the Brussels-Capital Region on its Brussels market. The Brussels-Capital Region is one of the three regions of Belgium. It covers the 19 municipalities of Brussels-Capital, and thus forms the […]
Apr 08 2014 @ 14:01
IPO raises €23 million – 4.7x oversubscribed, with total demand at €93.9 million EnterNext, the Euronext subsidiary designed to promote and grow its market for SMEs, today congratulated Genomic Vision, a biotechnology company specialising in molecular diagnostics for genetic diseases, on its successful listing in compartment C of Euronext’s regulated market in Paris. Genomic Vision...
Apr 05 2014 @ 09:37
NYSE:GTCL EnterNext, the Euronext subsidiary designed to promote and grow its market for SMEs, today welcomed GENTICEL, a French biotechnology company and specialist in the development of therapeutic vaccines whose objective is to eliminate the human papillomavirus (HPV) responsible for cervical cancer, on its successful admission to trading on Euronext’s compartment C in Paris and […]
Apr 02 2014 @ 14:25
Easy as ABO Euronext Brussels S.A./N.V., a wholly owned subsidiary of IntercontinentalExchange Group, Inc. (
NYSE:ICE), welcomed today ABO-Group on its regulated market. ABO-Group’s entry on Euronext Brussels’ market occurred through the reverse takeover of Thenergo, a developer, operator and service provider in the context of energy projects. ABO-Group manages a group of companies in Belgium...
Mar 30 2014 @ 16:12
Outokumpu announced today that the negotiations regarding the industrial plan have been successfully concluded with the employee representatives and unions in Germany. The industrial plan for Business Area EMEA Stainless was originally announced in October 2013, with a target of EUR 100 million annual savings, contributing to the overall annual synergy and cost savings of […]